Medical Countermeasures UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences FundGlobal Biodefense StaffSeptember 29, 2025
Contracts + Grants U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure ContractsGlobal Biodefense StaffSeptember 23, 2025
Pathogens New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum AntiviralsGlobal Biodefense StaffSeptember 23, 2025
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
COVID Moonshot Consortium Announces Crowd-Sourced Small Molecule Discovery Medical Countermeasures November 11, 2023 …
Phase 2 Clinical Trial for Marburg Vaccine Starts in Uganda Medical Countermeasures October 19, 2023 …
Novavax’s Prototype COVID-19 Vaccine Nuvaxovid Receives Full Approval in Singapore Medical Countermeasures October 18, 2023 …
Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster Medical Countermeasures September 20, 2023 …
Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant Contracts + Grants September 17, 2023 …
Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve Medical Countermeasures September 13, 2023 …
HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies Contracts + Grants September 8, 2023 …
Kyasanur Forest Disease: Promising Experimental Vaccine for Rare Tick-borne Flavivirus Medical Countermeasures September 7, 2023 …
Disease X: CEPI and University of Oxford Collaborate on Rapid Response Vaccine Technology Medical Countermeasures August 29, 2023 …
Chikungunya Vaccine: Health Canada Moves Forward with Valneva Review Medical Countermeasures August 29, 2023 …
CSL Seqirus Awarded Contract for Influenza A(H5N8) Candidate Vaccine Medical Countermeasures August 28, 2023 …
Allucent Awarded BARDA Contract to Accelerate Next-Generation COVID-19 Booster Vaccines Medical Countermeasures August 28, 2023 …
NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques Medical Countermeasures August 25, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …
Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy Industry News August 22, 2023 …
